|
|
|
Volumn 24, Issue 2, 1997, Pages 219-240
|
|
Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,11 DICHLORO 6 (2 DIETHYLAMINOETHYL) 12,13 DIHYDRO 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 (4 O METHYLGLUCOSIDE);
4 DEDIMETHYLAMINOSANCYCLINE;
5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE;
5 ETHYNYLURACIL;
6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE;
6 OMEGA BENZYLGUANINE;
7 HYDROXYSTAUROSPORINE;
ANTINEOPLASTIC AGENT;
BENZOYLPHENYLUREA DERIVATIVE;
BETA DIOXOLANE CYTIDINE;
BIZELESIN;
BRYOSTATIN 1;
DOLASTATIN;
FLAVOPIRIDOL;
FR 901228;
NALPHA [N (2 CHLOROETHYL) N NITROSOCARBAMOYL]SARCOSINAMIDE;
NELARABINE;
NSC 226080;
NSC 339555;
NSC 364432;
NSC 615291;
NSC 638037;
PENCLOMEDINE;
QUINOCARMYCIN;
QUINOCARMYCIN CITRATE;
RAPAMYCIN;
REBECCAMYCIN;
RHIZOXIN;
SPICAMYCIN;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SYNTHESIS;
ENZYME REGULATION;
GENE EXPRESSION REGULATION;
HUMAN;
PRIORITY JOURNAL;
TUMOR VASCULARIZATION;
ANTINEOPLASTIC AGENTS;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS;
DRUGS, INVESTIGATIONAL;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS;
UNITED STATES;
|
|
EID: 0030891357
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (54)
|
|
References (152)
|
